LUPIN ATLANTIS HOLDINGS SA has a total of 48 patent applications. It decreased the IP activity by 20.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are NEURODERM LTD, VECTURA LTD and SERENITY PHARMACEUTICALS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Brazil | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Canada | 3 | |
#6 | Israel | 3 | |
#7 | Mexico | 3 | |
#8 | Australia | 2 | |
#9 | Colombia | 2 | |
#10 | Chile | 1 | |
#11 | China | 1 | |
#12 | Cuba | 1 | |
#13 | Dominican Republic | 1 | |
#14 | EAPO (Eurasian Patent Organization) | 1 | |
#15 | Republic of Korea | 1 | |
#16 | Republic of Moldova | 1 | |
#17 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Biotechnology | |
#5 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Syringes | |
#5 | Peptides | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Separation |
# | Name | Total Patents |
---|---|---|
#1 | Zeng Xian-Ming | 13 |
#2 | Kamboj Rajender Kumar | 10 |
#3 | Palle Venkata P | 10 |
#4 | Kulkarni Sanjeev Anant | 9 |
#5 | Shukla Manojkumar Ramprasad | 8 |
#6 | Nayak Raghavendra | 7 |
#7 | Baviskar Mahesh | 7 |
#8 | Vekhande Ganesh | 7 |
#9 | Goller Michael | 7 |
#10 | Kumar Thommandru Vijaya | 7 |
Publication | Filing date | Title |
---|---|---|
US2018318214A1 | Pharmaceutical compositions of dronabinol | |
US2019224112A1 | Methods and Kit for Treating Skin Disorders | |
US2018161281A1 | Extended release pharmaceutical composition of mixed amphetamines | |
US2018098982A1 | Oral pharmaceutical composition of methylergonovine and methods of use thereof | |
US2018098942A1 | Oral pharmaceutical composition of methylergonovine and methods of use thereof | |
US2018116952A1 | Oral pharmaceutical composition of methylergonovine and methods of use thereof | |
US2018116953A1 | Oral pharmaceutical composition of methylergonovine and methods of use thereof | |
US2019076607A1 | Inhaler and mesh for an inhaler | |
WO2016187595A2 | Oral pharmaceutical composition of methylergonovine | |
MD20170094A2 | Process for manufacturing dry powder blends | |
BR112017011623A2 | pharmaceutical compositions and process for the preparation of a composition | |
US2016214924A1 | Substituted naphthalene compounds as calcium sensing receptor modulators |